New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study Group.

about

Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy.

P2860

Q38658450-6687CA85-5B4F-4681-A6EA-40A09DAB56A1

P2860

New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study Group.

Item

http://www.wikidata.org/entity/Q38817057

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

New quality assurance program ...... he German Hodgkin Study Group.

@en

type

Item

label

New quality assurance program ...... he German Hodgkin Study Group.

@en

prefLabel

New quality assurance program ...... he German Hodgkin Study Group.

@en

P1476

New quality assurance program ...... he German Hodgkin Study Group.

@en

P2093

A Engert

http://www.w3.org/2001/XMLSchema#string

C Baues

http://www.w3.org/2001/XMLSchema#string

H Schmidberger

http://www.w3.org/2001/XMLSchema#string

H T Eich

http://www.w3.org/2001/XMLSchema#string

J Kriz

http://www.w3.org/2001/XMLSchema#string

K Herfarth

http://www.w3.org/2001/XMLSchema#string

M Fuchs

http://www.w3.org/2001/XMLSchema#string

P Lukas

http://www.w3.org/2001/XMLSchema#string

R Engenhart-Cabillic

http://www.w3.org/2001/XMLSchema#string

S Marnitz-Schulze

http://www.w3.org/2001/XMLSchema#string

P2860

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.

Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group.

Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).

Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT.

Optimization by visualization of indices.

P2888

s00066-016-1048-y

P304

100-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00066-016-1048-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039275370

http://www.w3.org/2001/XMLSchema#string

P698

27678010

http://www.w3.org/2001/XMLSchema#string

New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study Group.

about

P2860

P2860

New quality assurance program integrating "modern radiotherapy" within the German Hodgkin Study Group.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698